COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS IN INDIAN HEALTHCARE SETTING

被引：0
|
作者：
Gokhale, S. [1 ]
Partha, G. [2 ]
Proudfoot, C. [3 ]
Anand, S. [1 ]
机构：
[1] Novartis Healthcare Pvt Ltd, Mumbai, Maharashtra, India
[2] Novartis Healthcare Pvt Ltd, Hyderabad, India
[3] Novartis Pharma AG, Basel, BS, Switzerland
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSC142
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction With a Recent Worsening Heart Failure Event
    Dixit, Neal
    Truong, Katie
    Ziaeian, Boback
    Fonarow, Gregg C.
    CIRCULATION, 2023, 148
  • [32] COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/VALSARTAN COMPARED WITH STANDARD ACEI THERAPIES FOR HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION IN TAIWAN
    Fann, C.
    Chen, S.
    VALUE IN HEALTH, 2017, 20 (09) : A617 - A617
  • [33] THE COST EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN KOREA
    Lee, J.
    Ko, S.
    VALUE IN HEALTH, 2017, 20 (09) : A617 - A618
  • [34] Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System
    Wang, Zhe
    Lou, Yake
    Wang, Qi
    Sun, Min
    Li, Xiaonan
    Wang, Yinghui
    Wang, Yuehui
    CLINICAL DRUG INVESTIGATION, 2023, 43 (04) : 265 - 275
  • [35] Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System
    Zhe Wang
    Yake Lou
    Qi Wang
    Min Sun
    Xiaonan Li
    Yinghui Wang
    Yuehui Wang
    Clinical Drug Investigation, 2023, 43 : 265 - 275
  • [36] Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction
    King, Jordan B.
    Shah, Rashmee U.
    Bress, Adam P.
    Nelson, Richard E.
    Bellows, Brandon K.
    JACC-HEART FAILURE, 2016, 4 (05) : 392 - 402
  • [37] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [38] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN (FORMERLY LCZ696) IN CHRONIC HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION - AN ANALYSIS FOR SWITZERLAND
    Ademi, Z.
    Hancock, E.
    Trueman, D.
    Pfeil, A.
    Haroun, R.
    Deschaseaux, C.
    Schwenkglenks, M.
    VALUE IN HEALTH, 2016, 19 (07) : A655 - A655
  • [39] Cost-Effectiveness of Sacubitril-Valsartan Compared to Angiotensin-Converting Enzyme Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction
    Febrinasari, Ratih P.
    Putra, Stefanus E.
    Hafizhan, Muhammad
    Probandari, Ari N.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 915 - 924
  • [40] Clinical Effectiveness of Sacubitril/valsartan among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction
    Greene, Stephen J.
    Lippmann, Steven J.
    Mentz, Robert J.
    Greiner, Melissa A.
    Hardy, N. Chantelle
    Chang, Chun-Lan
    Hammill, Bradley G.
    Luo, Nancy
    Samsky, Marc D.
    Heidenreich, Paul A.
    Laskey, Warren K.
    Yancy, Clyde W.
    Peterson, Pamela N.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    O'Brien, Emily C.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (11) : 937 - 937
12345